Charu chaudhry

Company: Johnson & Johnson Innovative Medicine

Job title: Associate Director

Seminars:

Roundtable Discussion: Expanding E3 ligase Platforms for Targeted Protein Degradation 1:30 pm

Current state of the art, selection of Next-Gen E3 ligases and winning screening strategies, e.g. Rational design Hit ID, phenotypic function 1st, computational AI-ML Accelerated workflows for binder to degrader conversion Tissue- specific and tissue restricted TPD : has this underdelivered and what are the main obstacles? Expanding molecular glue potential of E3 ligandsRead more

day: Bootcamp Day